Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2011, Article ID 810619, 12 pages
http://dx.doi.org/10.4061/2011/810619
Review Article

Mitochondria and PGC-1α in Aging and Age-Associated Diseases

Institute for Genetics, Cluster of Excellence, Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Zülpicher Straße 47A, 50674 Cologne, Germany

Received 15 October 2010; Revised 23 February 2011; Accepted 24 February 2011

Academic Editor: Reinald Pamplona

Copyright © 2011 Tina Wenz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Harman, “The biologic clock: the mitochondria?” Journal of the American Geriatrics Society, vol. 20, no. 4, pp. 145–147, 1972. View at Google Scholar · View at Scopus
  2. A. Trifunovic and N. G. Larsson, “Mitochondrial dysfunction as a cause of ageing,” Journal of Internal Medicine, vol. 263, no. 2, pp. 167–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. I. R. Lanza and K. S. Nair, “Mitochondrial function as a determinant of life span,” Pflugers Archiv European Journal of Physiology, vol. 459, no. 2, pp. 277–289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Guarente, “Mitochondria-A nexus for aging, calorie restriction, and sirtuins?” Cell, vol. 132, no. 2, pp. 171–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Handschin, “The biology of PGC-1α and its therapeutic potential,” Trends in Pharmacological Sciences, vol. 30, no. 6, pp. 322–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Wenz, “PGC-1α activation as a therapeutic approach in mitochondrial disease,” IUBMB Life, vol. 61, no. 11, pp. 1051–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Saraste, “Oxidative phosphorylation at the fin de siecle,” Science, vol. 283, no. 5407, pp. 1488–1493, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Orrenius, V. Gogvadze, and B. Zhivotovsky, “Mitochondrial oxidative stress: implications for cell death,” Annual Review of Pharmacology and Toxicology, vol. 47, pp. 143–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Y. Andreyev, YU. E. Kushnareva, and A. A. Starkov, “Mitochondrial metabolism of reactive oxygen species,” Biochemistry, vol. 70, no. 2, pp. 200–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Cadenas and K. J. A. Davies, “Mitochondrial free radical generation, oxidative stress, and aging,” Free Radical Biology and Medicine, vol. 29, no. 3-4, pp. 222–230, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. J. St-Pierre, J. A. Buckingham, S. J. Roebuck, and M. D. Brand, “Topology of superoxide production from different sites in the mitochondrial electron transport chain,” The Journal of Biological Chemistry, vol. 277, no. 47, pp. 44784–44790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Miquel, A. C. Economos, J. Fleming, and J. E. Johnson, “Mitochondrial role in cell aging,” Experimental Gerontology, vol. 15, no. 6, pp. 575–591, 1980. View at Publisher · View at Google Scholar · View at Scopus
  13. C. C. Kujoth, A. Hiona, T. D. Pugh et al., “Medicine: mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging,” Science, vol. 309, no. 5733, pp. 481–484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Trifunovic, A. Hansson, A. Wredenberg et al., “Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 17993–17998, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Wang, J. P. Silva, C. M. Gustafsson, P. Rustin, and N. G. Larsson, “Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 4038–4043, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. R. S. Balaban, S. Nemoto, and T. Finkel, “Mitochondria, oxidants, and aging,” Cell, vol. 120, no. 4, pp. 483–495, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Van Remmen, Y. Ikeno, M. Hamilton et al., “Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging,” Physiological Genomics, vol. 16, pp. 29–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Van Remmen, W. Qi, M. Sabia et al., “Multiple deficiencies in antioxidant enzymes in mice result in a compound increase in sensitivity to oxidative stress,” Free Radical Biology and Medicine, vol. 36, no. 12, pp. 1625–1634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. T. T. Huang, E. J. Carlson, A. M. Gillespie, Y. Shi, and C. J. Epstein, “Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice,” Journals of Gerontology—Series A, vol. 55, no. 1, pp. B5–B9, 2000. View at Google Scholar · View at Scopus
  20. S. Miwa, K. Riyahi, L. Partridge, and M. D. Brand, “Lack of correlation between mitochondrial reactive oxygen species production and life span in Drosophila,” Annals of the New York Academy of Sciences, vol. 1019, pp. 388–391, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-Y. Lee, C. S. Choi, A. L. Birkenfeld et al., “Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance,” Cell Metabolism, vol. 12, no. 6, pp. 668–674, 2010. View at Publisher · View at Google Scholar
  22. D. F. Dai, L. F. Santana, M. Vermulst et al., “Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging,” Circulation, vol. 119, no. 21, pp. 2789–2797, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. P. M. Treuting, N. J. Linford, S. E. Knoblaugh et al., “Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria,” Journals of Gerontology—Series A, vol. 63, no. 8, pp. 813–824, 2008. View at Google Scholar · View at Scopus
  24. S. E. Schriner, N. J. Linford, G. M. Martin et al., “Medecine: extension of murine life span by overexpression of catalase targeted to mitochondria,” Science, vol. 308, no. 5730, pp. 1909–1911, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. A. V. Ergen and M. A. Goodell, “Mechanisms of hematopoietic stem cell aging,” Experimental Gerontology, vol. 45, no. 4, pp. 286–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Someya and T. A. Prolla, “Mitochondrial oxidative damage and apoptosis in age-related hearing loss,” Mechanisms of Ageing and Development, vol. 131, no. 7-8, pp. 480–486, 2010. View at Publisher · View at Google Scholar
  27. K. K. Ohlemiller, S. L. McFadden, DA. L. Ding et al., “Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss,” Audiology and Neuro-Otology, vol. 4, no. 5, pp. 237–246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Someya, J. Xu, K. Kondo et al., “Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 46, pp. 19432–19437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Li, N. Y. Calingasan, F. Yu et al., “Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice,” Journal of Neurochemistry, vol. 89, no. 5, pp. 1308–1312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Melov, P. A. Adlard, K. Morten et al., “Mitochondrial oxidative stress causes hyperphosphorylation of tau,” PLoS ONE, vol. 2, no. 6, article e536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Ohashi, M. S. Runge, F. M. Faraci, and D. D. Heistad, “MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 10, pp. 2331–2336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Vincent, J. W. Russell, K. A. Sullivan et al., “SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy,” Experimental Neurology, vol. 208, no. 2, pp. 216–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. D. S. Albers and M. Flint Beal, “Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease,” Journal of Neural Transmission, Supplement, no. 59, pp. 133–154, 2000. View at Google Scholar · View at Scopus
  34. M. Ristow and K. Zarse, “How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis),” Experimental Gerontology, vol. 45, no. 6, pp. 410–418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Ristow, K. Zarse, A. Oberbach et al., “Antioxidants prevent health-promoting effects of physical exercise in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8665–8670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis,” Journal of the American Medical Association, vol. 297, no. 8, pp. 842–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Yang and S. Hekimi, “A mitochondrial superoxide signal triggers increased longevity in caenorhabditis elegans,” PLoS Biology, vol. 8, no. 12, 2010. View at Publisher · View at Google Scholar
  38. R. Scherz-Shouval and Z. Elazar, “Regulation of autophagy by ROS: physiology and pathology,” Trends in Biochemical Sciences, vol. 36, no. 1, pp. 30–38, 2011. View at Publisher · View at Google Scholar
  39. J. Papaconstantinou, “Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination,” Molecular and Cellular Endocrinology, vol. 299, no. 1, pp. 89–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Giorgio, E. Migliaccio, F. Orsini et al., “Electron transfer between cytochrome c and p66 generates reactive oxygen species that trigger mitochondrial apoptosis,” Cell, vol. 122, no. 2, pp. 221–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. R. C. Scarpulla, “Transcriptional paradigms in mammalian mitochondrial biogenesis and function,” Physiological Reviews, vol. 88, no. 2, pp. 611–638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. R. C. Scarpulla, “Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator,” Annals of the New York Academy of Sciences, vol. 1147, pp. 321–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Puigserver and B. M. Spiegelman, “Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator,” Endocrine Reviews, vol. 24, no. 1, pp. 78–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Kang and N. Hamasaki, “Mitochondrial transcription factor A in the maintenance of mitochondrial DNA: overview of its multiple roles,” Annals of the New York Academy of Sciences, vol. 1042, pp. 101–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Bastin, F. Aubey, A. Rötig, A. Munnich, and F. Djouadi, “Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 4, pp. 1433–1441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Wenz, F. Diaz, B. M. Spiegelman, and C. T. Moraes, “Activation of the PPAR/PGC-1α pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype,” Cell Metabolism, vol. 8, no. 3, pp. 249–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Wenz et al., “A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations,” Journal of Cellular and Molecular Medicine. In press.
  48. R. Barrès, M. E. Osler, J. Yan et al., “Non-CpG Methylation of the PGC-1α Promoter through DNMT3B Controls Mitochondrial Density,” Cell Metabolism, vol. 10, no. 3, pp. 189–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Fan, J. Rhee, J. St-Pierre et al., “Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1α: modulation by p38 MAPK,” Genes and Development, vol. 18, no. 3, pp. 278–289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. A. M. Powelka, A. Seth, J. V. Virbasius et al., “Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes,” Journal of Clinical Investigation, vol. 116, no. 1, pp. 125–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Cantó and J. Auwerx, “PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure,” Current Opinion in Lipidology, vol. 20, no. 2, pp. 98–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Planavila et al., “Sirt1 acts in association with PPARa to protect the heart from hypertrophy, metabolic dysregulation, and inflammation,” Cardiovascular Research. In press.
  54. D. Beher, J. Wu, S. Cumine et al., “Resveratrol is not a direct activator of sirt1 enzyme activity,” Chemical Biology and Drug Design, vol. 74, no. 6, pp. 619–624, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Dai, L. Kustigian, D. Carney et al., “SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator,” The Journal of Biological Chemistry, vol. 285, no. 43, pp. 32695–32703, 2010. View at Publisher · View at Google Scholar
  56. C. Ling, P. Poulsen, E. Carlsson et al., “Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins,” Journal of Clinical Investigation, vol. 114, no. 10, pp. 1518–1526, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. R. J. Southgate, C. R. Bruce, A. L. Carey et al., “PGC-1α gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle,” FASEB Journal, vol. 19, no. 14, pp. 2072–2074, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Akimoto, S. C. Pohnert, P. Li et al., “Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway,” The Journal of Biological Chemistry, vol. 280, no. 20, pp. 19587–19593, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. R. M. Anderson, J. L. Barger, M. G. Edwards et al., “Dynamic regulation of PGC-1α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response,” Aging Cell, vol. 7, no. 1, pp. 101–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. P. Housley, N. D. Udeshi, J. T. Rodgers et al., “A PGC-1α-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose,” The Journal of Biological Chemistry, vol. 284, no. 8, pp. 5148–5157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. M. Rytinki and J. J. Palvimo, “SUMOylation attenuates the function of PGC-1α,” The Journal of Biological Chemistry, vol. 284, no. 38, pp. 26184–26193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. S. DiMauro and E. A. Schon, “Mitochondrial disorders in the nervous system,” Annual Review of Neuroscience, vol. 31, pp. 91–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. D. J. Baker, A. C. Betik, D. J. Krause, and R. T. Hepple, “No decline in skeletal muscle oxidative capacity with aging in long-term calorically restricted rats: effects are independent of mitochondrial DNA integrity,” Journals of Gerontology—Series A, vol. 61, no. 7, pp. 675–684, 2006. View at Google Scholar · View at Scopus
  64. A. E. Civitarese, S. Carling, L. K. Heilbronn et al., “Calorie restriction increases muscle mitochondrial biogenesis in healthy humans,” PLoS Medicine, vol. 4, no. 3, pp. 485–494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. G. P. Fadini, G. Ceolotto, E. Pagnin, S. De Kreutzenberg, and A. Avogaro, “At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways,” Aging Cell, vol. 10, no. 1, pp. 10–17, 2011. View at Publisher · View at Google Scholar
  66. E. Sahin, S. Colla, M. Liesa et al., “Telomere dysfunction induces metabolic and mitochondrial compromise,” Nature, vol. 470, no. 7334, pp. 359–365, 2011. View at Publisher · View at Google Scholar
  67. A. A. Gonzalez, R. Kumar, J. D. Mulligan, A. J. Davis, and K. W. Saupe, “Effects of aging on cardiac and skeletal muscle AMPK activity: basal activity, allosteric activation, and response to in vivo hypoxemia in mice,” American Journal of Physiology, vol. 287, no. 5 56-5, pp. R1270–R1275, 2004. View at Publisher · View at Google Scholar
  68. T. Wenz, S. G. Rossi, R. L. Rotundo, B. M. Spiegelman, and C. T. Moraes, “Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 48, pp. 20405–20410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Baar, A. R. Wende, T. E. Jones et al., “Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1,” FASEB Journal, vol. 16, no. 14, pp. 1879–1886, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Handschin, “Regulation of skeletal muscle cell plasticity by the peroxisome proliferator-activated receptor γ coactivator 1α,” Journal of Receptors and Signal Transduction, vol. 30, no. 6, pp. 376–384, 2010. View at Publisher · View at Google Scholar
  71. W. Cao, K. W. Daniel, J. Robidoux et al., “p38 Mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene,” Molecular and Cellular Biology, vol. 24, no. 7, pp. 3057–3067, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Puigserver, J. Rhee, J. Lin et al., “Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγ coactivator-1,” Molecular Cell, vol. 8, no. 5, pp. 971–982, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Lin, H. Wu, P. T. Tarr et al., “Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres,” Nature, vol. 418, no. 6899, pp. 797–801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Wenz, F. Diaz, D. Hernandez, and C. T. Moraes, “Endurance exercise is protective for mice with mitochondrial myopathy,” Journal of Applied Physiology, vol. 106, no. 5, pp. 1712–1719, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Handschin, Y. M. Kobayashi, S. Chin, P. Seale, K. P. Campbell, and B. M. Spiegelman, “PGC-1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy,” Genes and Development, vol. 21, no. 7, pp. 770–783, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Sandri, J. Lin, C. Handschin et al., “PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 44, pp. 16260–16265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. A. -S. Arnold, A. Egger, and C. Handschin, “PGC-1α and myokines in the aging muscle—a mini-review,” Gerontology, vol. 57, no. 1, pp. 37–43, 2010. View at Publisher · View at Google Scholar
  78. C. Handschin, “Peroxisome proliferator-activated receptor-γ coactivator-1α in muscle links metabolism to inflammation,” Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 12, pp. 1139–1143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Chinsomboon, J. Ruas, R. K. Gupta et al., “The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 50, pp. 21401–21406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. C. M. Lee, M. E. Lopez, R. Weindruch, and J. M. Aiken, “Association of age-related mitochondrial abnormalities with skeletal muscle fiber atrophy,” Free Radical Biology and Medicine, vol. 25, no. 8, pp. 964–972, 1998. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Marzetti, H. A. Lees, S. E. Wohlgemuth, and C. Leeuwenburgh, “Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction,” BioFactors, vol. 35, no. 1, pp. 28–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. J. M. Huss and D. P. Kelly, “Nuclear receptor signaling and cardiac energetics,” Circulation Research, vol. 95, no. 6, pp. 568–578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. M. P. Czubryt et al., “Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 a (PGC-1 a ) and mitochondrial function by MEF2 and HDAC5,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 1711–1716, 2003. View at Google Scholar
  84. B. T. O'Neill, J. Kim, A. R. Wende et al., “A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy,” Cell Metabolism, vol. 6, no. 4, pp. 294–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. Z. Arany, H. He, J. Lin et al., “Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle,” Cell Metabolism, vol. 1, no. 4, pp. 259–271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. T. C. Leone, J. J. Lehman, B. N. Finck et al., “PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis.,” PLoS Biology, vol. 3, no. 4, p. e101, 2005. View at Google Scholar · View at Scopus
  87. J. M. Huss and D. P. Kelly, “Mitochondrial energy metabolism in heart failure: a question of balance,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 547–555, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. L. K. Russell, C. M. Mansfield, J. J. Lehman et al., “Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner,” Circulation Research, vol. 94, no. 4, pp. 525–533, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. E. G. Lynn, M. V. Stevens, R. P. Wong et al., “Transient upregulation of PGC-1α diminishes cardiac ischemia tolerance via upregulation of ANT1,” Journal of Molecular and Cellular Cardiology, vol. 49, no. 4, pp. 693–698, 2010. View at Publisher · View at Google Scholar
  90. G. C. Rowe, A. Jiang, and Z. Arany, “PGC-1 coactivators in cardiac development and disease,” Circulation Research, vol. 107, no. 7, pp. 825–838, 2010. View at Publisher · View at Google Scholar
  91. J. St-Pierre, S. Drori, M. Uldry et al., “Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators,” Cell, vol. 127, no. 2, pp. 397–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Lin, P. H. Wu, P. T. Tarr et al., “Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice,” Cell, vol. 119, no. 1, pp. 121–135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. R. M. Cowell, P. Talati, K. R. Blake, J. H. Meador-Woodruff, and J. W. Russell, “Identification of novel targets for PGC-1α and histone deacetylase inhibitors in neuroblastoma cells,” Biochemical and Biophysical Research Communications, vol. 379, no. 2, pp. 578–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Bender, K. J. Krishnan, C. M. Morris et al., “High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease,” Nature Genetics, vol. 38, no. 5, pp. 515–517, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. L. Cui, H. Jeong, F. Borovecki, C. N. Parkhurst, N. Tanese, and D. Krainc, “Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration,” Cell, vol. 127, no. 1, pp. 59–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Weydt, V. V. Pineda, A. E. Torrence et al., “Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration,” Cell Metabolism, vol. 4, no. 5, pp. 349–362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. W. Qin, V. Haroutunian, P. Katsel et al., “PGC-1α expression decreases in the Alzheimer disease brain as a function of dementia,” Archives of Neurology, vol. 66, no. 3, pp. 352–361, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Y. Sun, Q. Wang, A. Simonyi, and G. Y. Sun, “Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases,” Molecular Neurobiology, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. J. C. Yoon, P. Puigserver, G. Chen et al., “Control of hepatic gluconeogenesis through the transcriptional coaotivator PGC-1,” Nature, vol. 413, no. 6852, pp. 131–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. P. Puigserver, J. Rhee, J. Donovan et al., “Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction,” Nature, vol. 423, no. 6939, pp. 550–555, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Rhee, Y. Inoue, J. C. Yoon et al., “Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): requirement for hepatocyte nuclear factor 4α in gluconeogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 4012–4017, 2003. View at Publisher · View at Google Scholar
  102. W. Cao, Q. F. Collins, T. C. Becker et al., “p38 mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis,” The Journal of Biological Chemistry, vol. 280, no. 52, pp. 42731–42737, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. F. C. Qu, Y. Xiong, E. G. Lupo, H. Y. Liu, and W. Cao, “p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes,” The Journal of Biological Chemistry, vol. 281, no. 34, pp. 24336–24344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. C. R. Hancock, D. H. Han, M. Chen et al., “High-fat diets cause insulin resistance despite an increase in muscle mitochondria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 22, pp. 7815–7820, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. R. Boushel, E. Gnaiger, P. Schjerling, M. Skovbro, R. Kraunsøe, and F. Dela, “Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle,” Diabetologia, vol. 50, no. 4, pp. 790–796, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. J. A. Pospisilik, C. Knauf, N. Joza et al., “Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes,” Cell, vol. 131, no. 3, pp. 476–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. K. F. Petersen, D. Befroy, S. Dufour et al., “Mitochondrial dysfunction in the elderly: possible role in insulin resistance,” Science, vol. 300, no. 5622, pp. 1140–1142, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. J. F. Dumas, G. Simard, M. Flamment, P. H. Ducluzeau, and P. Ritz, “Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?” Diabetes and Metabolism, vol. 35, no. 3, pp. 159–167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. J. A. Kim, Y. Wei, and J. R. Sowers, “Role of mitochondrial dysfunction in insulin resistance,” Circulation Research, vol. 102, no. 4, pp. 401–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. M. E. Patti, A. J. Butte, S. Crunkhorn et al., “Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8466–8471, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Wang, A. Kamat, P. Pergola, A. Swamy, F. Tio, and K. Cusi, “Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo,” Metabolism. In press.
  112. A. A. Gupte, J. Z. Liu, Y. Ren et al., “Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice,” Hepatology, vol. 52, no. 6, pp. 2001–2011, 2010. View at Publisher · View at Google Scholar
  113. Y. Hayashi, M. Yoshida, M. Yamato et al., “Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor A in mice,” Journal of Neuroscience, vol. 28, no. 34, pp. 8624–8634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Xu, M. Zhong, L. Zhang et al., “Overexpression of Tfam protects mitochondria against β-amyloid-induced oxidative damage in SH-SY5Y cells,” FEBS Journal, vol. 276, no. 14, pp. 4224–4233, 2009. View at Publisher · View at Google Scholar
  115. M. Ikeuchi, H. Matsusaka, D. Kang et al., “Overexpression of mitochondrial transcription factor A ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction,” Circulation, vol. 112, no. 5, pp. 683–690, 2005. View at Publisher · View at Google Scholar
  116. L. Mahishi and K. Usdin, “NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2),” Biochemical Journal, vol. 400, no. 2, pp. 327–335, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. A. G. Rosmarin, K. K. Resendes, Z. Yang, J. N. McMillan, and S. L. Fleming, “GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions,” Blood Cells, Molecules, and Diseases, vol. 32, no. 1, pp. 143–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. S. Yu, K. Cui, R. Jothi et al., “GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells,” Blood, vol. 117, no. 7, pp. 2166–2178, 2011. View at Publisher · View at Google Scholar
  119. L. M. Angus, J. V. Chakkalakal, A. Méjat et al., “Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1α, drives utrophin gene expression at the neuromuscular junction,” American Journal of Physiology, vol. 289, no. 4, pp. C908–C917, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. X. Kong, R. Wang, Y. Xue et al., “Sirtuin 3, a new target of PGC-1α, plays an important role in the suppression of ROS and mitochondrial biogenesis,” PLoS ONE, vol. 5, no. 7, Article ID e11707, 2010. View at Publisher · View at Google Scholar
  121. E. Verdin, M. D. Hirschey, L. W.S. Finley, and M. C. Haigis, “Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling,” Trends in Biochemical Sciences, vol. 35, no. 12, pp. 669–675, 2010. View at Publisher · View at Google Scholar
  122. A. V. Hafner, J. Dai, A. P. Gomes et al., “Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy,” Aging, vol. 2, no. 12, pp. 914–923, 2010. View at Google Scholar
  123. J. Sadoshima, “Sirt3 targets mPTP and prevents aging in the heart,” Aging, vol. 3, no. 1, pp. 12–13, 2011. View at Google Scholar
  124. A. Bartke, M. Masternak, K. Al-Regaiey, and M. Bonkowski, “Effects of dietary restriction on the expression of insulin-signaling- related genes in long-lived mutant mice,” Interdisciplinary Topics in Gerontology, vol. 35, pp. 69–82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. L. Bordone and L. Guarente, “Calorie restriction, SIRT1 and metabolism: understanding longevity,” Nature Reviews Molecular Cell Biology, vol. 6, no. 4, pp. 298–305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. S. J. Lin and L. Guarente, “Increased life span due to calorie restriction in respiratory-deficient yeast,” PLoS Genetics, vol. 2, no. 3, p. e33, 2006. View at Google Scholar
  127. J. J. Ramsey, R. J. Colman, N. C. Binkley et al., “Dietary restriction and aging in rhesus monkeys: the University of Wisconsin study,” Experimental Gerontology, vol. 35, no. 9-10, pp. 1131–1149, 2000. View at Publisher · View at Google Scholar · View at Scopus
  128. R. Weindruch, R. L. Walford, S. Fligiel, and D. Guthrie, “The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake,” Journal of Nutrition, vol. 116, no. 4, pp. 641–654, 1986. View at Google Scholar · View at Scopus
  129. A. E. Civitarese, S. R. Smith, and E. Ravussin, “Diet, energy metabolism and mitochondrial biogenesis,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 6, pp. 679–687, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. J. T. Rodgers, C. Lerin, Z. Gerhart-Hines, and P. Puigserver, “Metabolic adaptations through the PGC-1α and SIRT1 pathways,” FEBS Letters, vol. 582, no. 1, pp. 46–53, 2008. View at Publisher · View at Google Scholar
  131. S. Nemoto, M. M. Fergusson, and T. Finkel, “SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α,” The Journal of Biological Chemistry, vol. 280, no. 16, pp. 16456–16460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  132. G. Arunachalam, H. Yao, I. K. Sundar, S. Caito, and I. Rahman, “SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol,” Biochemical and Biophysical Research Communications, vol. 393, no. 1, pp. 66–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. M. C. Haigis and D. A. Sinclair, “Mammalian sirtuins: biological insights and disease relevance,” Annual Review of Pathology, vol. 5, pp. 253–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. J. A. Baur, D. Chen, E. N. Chini et al., “Dietary restriction: standing up for sirtuins,” Science, vol. 329, no. 5995, pp. 1012–1013, 2010. View at Publisher · View at Google Scholar
  135. F. Dela and M. Kjaer, “Resistance training, insulin sensitivity and muscle function in the elderly,” Essays in Biochemistry, vol. 42, pp. 75–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. R. A. Winett and R. N. Carpinelli, “Potential health-related benefits of resistance training,” Preventive Medicine, vol. 33, no. 5, pp. 503–513, 2001. View at Publisher · View at Google Scholar · View at Scopus
  137. V. A. Lira, C. R. Benton, Z. Yan, and A. Bonen, “PGC-1α regulation by exercise training and its influences on muscle function and insulin sensitivity,” American Journal of Physiology, vol. 299, no. 2, pp. E145–E161, 2010. View at Publisher · View at Google Scholar
  138. Z. Yan, “Exercise, PGC-1α, and metabolic adaptation in skeletal muscle,” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 3, pp. 424–427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  140. S. B. Jorgensen and A. J. Rose, “How is AMPK activity regulated in skeletal muscles during exercise?” Frontiers in Bioscience, vol. 13, pp. 5589–5604, 2008. View at Google Scholar · View at Scopus
  141. J. O. Lee, S. K. Lee, J. H. Jung et al., “Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells,” Journal of Cellular Physiology, vol. 226, no. 4, pp. 974–981, 2011. View at Publisher · View at Google Scholar
  142. W. J. Lee, M. Kim, H. S. Park et al., “AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARα and PGC-1,” Biochemical and Biophysical Research Communications, vol. 340, no. 1, pp. 291–295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  143. L. F. Michael, Z. Wu, R. B. Cheatham et al., “Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 3820–3825, 2001. View at Publisher · View at Google Scholar · View at Scopus
  144. R. A. Quintanilla, Y. N. Jin, K. Fuenzalida, M. Bronfman, and G. V. W. Johnson, “Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-γ (PPARγ) in the pathogenesis of huntington disease,” The Journal of Biological Chemistry, vol. 283, no. 37, pp. 25628–25637, 2008. View at Publisher · View at Google Scholar